- Home
- / Lepu Biopharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lepu Biopharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$5.4
2023-08-30
Market Capitalization
$8.7 B
2023-08-30
Revenue
¥15.6 M
FY, 2022
CreditSafe Score
?
Score changed on Sept 25, 2023
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|
| Revenue | 15.6M | |||
| Cost of goods sold | 2.0M | |||
| Gross profit | 3.5M | 2.9M | 5.6M | 24.7M |
| Gross profit margin, % | 158.5% | |||
| Operating expense total | 372.4M | 366.0M | 853.3M | 570.1M |
| Depreciation and amortization | 49.3M | 84.1M | 95.2M | 95.4M |
| EBITDA | (377.5M) | (375.2M) | (865.4M) | (577.7M) |
| EBITDA margin, % | -3709.9% | |||
| EBIT | (426.7M) | (459.3M) | (961.6M) | (673.9M) |
| EBIT margin, % | -4327.9% | |||
| Interest income | 396.0K | 5.3M | 4.1M | 45.9M |
| Interest expense | 52.6M | 86.3M | 3.3M | 8.6M |
| Pre tax profit | (515.5M) | (613.4M) | (1.0B) | (699.4M) |
| Net Income | (515.5M) | (613.4M) | (1.0B) | (699.4M) |